PMID- 30484525
OWN - NLM
STAT- MEDLINE
DCOM- 20190206
LR  - 20240229
IS  - 1806-4841 (Electronic)
IS  - 0365-0596 (Print)
IS  - 0365-0596 (Linking)
VI  - 93
IP  - 6
DP  - 2018 Nov/Dec
TI  - Impact of psoriasis in the quality of life of children, adolescents and their 
      families: a cross-sectional study.
PG  - 819-823
LID - S0365-0596(20)30544-4 [pii]
LID - 10.1590/abd1806-4841.20186981 [doi]
AB  - BACKGROUND: Psoriasis is a chronic and inflammatory disease that impairs quality 
      of life and causes psychological symptoms. Despite the high prevalence of 
      psoriasis in pediatric patients, studies investigating the impact of psoriasis in 
      the quality of life of children, adolescents and families are sparse. OBJECTIVE: 
      To investigate the impact of psoriasis in the quality of life of children and 
      adolescents with psoriasis and their families and to determine depression and 
      anxiety levels of the patients. METHODS: A total of 58 patients with psoriasis 
      aged 7-18 years (median age: 11) and a family member of each patient were 
      included in the study. Children's Dermatology Life Quality Index (CDLQI), Family 
      Dermatology Life Quality Index (FDLQI), Children's Depression Inventory (CDI) and 
      State-Trait Anxiety Inventory for Children (STAIC) were used in the study. 
      RESULTS: The median PASI score of the patients included in the study was 1.8. The 
      median CDLQI and FDLQI scores in the study groups were 5 and 10, respectively. 
      The median CDI score, STAIC-state and STAIC-trait scores of the patients were 6, 
      28 and 32.5, respectively. STUDY LIMITATIONS: Lack of a control group and patient 
      assessment of disease severity. Relatively mild disease severity of the subjects. 
      CONCLUSIONS: Psoriasis has a negative impact in the quality of life of children, 
      adolescents and their families, even in the presence of mild disease. Considering 
      that impairment in quality of life may be associated with psychosocial morbidity, 
      a combined approach with medical therapy, family counseling and quality of life 
      assessment may be beneficial in this patient group.
FAU - Salman, Andac
AU  - Salman A
AUID- ORCID: 0000-0002-6407-926X
AD  - Department of Dermatology, Marmara University School of Medicine, Pendik Research 
      and Training Hospital, Istanbul, Turkey.
FAU - Yucelten, Ayse Deniz
AU  - Yucelten AD
AUID- ORCID: 0000-0002-4251-0581
AD  - Department of Dermatology, Marmara University School of Medicine, Pendik Research 
      and Training Hospital, Istanbul, Turkey.
FAU - Sarac, Esra
AU  - Sarac E
AUID- ORCID: 0000-0002-9870-9733
AD  - Department of Dermatology, Koc University Hospital, Istanbul, Turkey.
FAU - Saricam, Merve Hatun
AU  - Saricam MH
AUID- ORCID: 0000-0002-9230-2190
AD  - Department of Dermatology, Oltu State Hospital, Erzurum, Turkey.
FAU - Perdahli-Fis, Nese
AU  - Perdahli-Fis N
AUID- ORCID: 0000-0002-4806-0876
AD  - Department of Child and Adolescent Psychiatry, Marmara University School of 
      Medicine, Pendik Research and Training Hospital, Istanbul, Turkey.
LA  - eng
PT  - Journal Article
PL  - Spain
TA  - An Bras Dermatol
JT  - Anais brasileiros de dermatologia
JID - 0067662
SB  - IM
MH  - Adolescent
MH  - Anxiety/*psychology
MH  - Child
MH  - Cross-Sectional Studies
MH  - Depression/*psychology
MH  - Family/*psychology
MH  - Female
MH  - Humans
MH  - Male
MH  - Psoriasis/*psychology
MH  - Quality of Life/*psychology
MH  - Severity of Illness Index
MH  - Surveys and Questionnaires
PMC - PMC6256235
COIS- Conflict of interest: None.
EDAT- 2018/11/30 06:00
MHDA- 2019/02/07 06:00
PMCR- 2018/11/01
CRDT- 2018/11/29 06:00
PHST- 2017/01/28 00:00 [received]
PHST- 2017/08/06 00:00 [accepted]
PHST- 2018/11/29 06:00 [entrez]
PHST- 2018/11/30 06:00 [pubmed]
PHST- 2019/02/07 06:00 [medline]
PHST- 2018/11/01 00:00 [pmc-release]
AID - S0365-0596(20)30544-4 [pii]
AID - 10.1590/abd1806-4841.20186981 [doi]
PST - ppublish
SO  - An Bras Dermatol. 2018 Nov/Dec;93(6):819-823. doi: 10.1590/abd1806-4841.20186981.